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Abstract
Introduction: Edwardsiella tarda uncommonly infects humans. The usual presentation is mild gastroenteritis, but
systemic manifestations may occur. Lethal infections are rarely documented in patients with underlying disorders.
Case presentation: A previously healthy 37-year-old Southeast Asian woman presented to our hospital with recent
onset of abdominal pain, fever, and vomiting. Her condition rapidly deteriorated with signs and symptoms of
fulminant septic shock; thus, she was intubated, supported with intravenous vasopressors and fluids, and transferred
to the intensive care unit. An abdominal computed tomographic scan with contrast revealed multiple liver
abscesses. Blood cultures were obtained and computed tomography–guided percutaneous drainage of the liver
abscesses with supplementary cultures was performed; thereafter, empirical broad-spectrum antibiotics were
initiated. All cultures grew E. tarda, whereas an antibiogram showed resistance to broad-spectrum antibiotics and
sensitivity to ciprofloxacin and aminoglycosides; thus, the antibiotic regimen was updated accordingly. The patient
made an uneventful recovery and was discharged from the intensive care unit 14 days after admission.
Conclusion: E. tarda human infection can present as liver abscess and fulminant septic shock. E. tarda strains can
be resistant to broad-spectrum antibiotics; hence, culture-based antibiotics should be used accordingly. Clinicians
should be aware of this rare and potentially lethal infection.
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Introduction
Edwardsiella tarda is a gram-negative, facultative anaer-
obe that is a member of the family Enterobacteriaceae
and was first described by Ewing et al. in 1965 [1]. Since
then, a growing body of literature has reported E. tarda
isolates particularly related to brackish water and marine
ecosystems, including reptiles, amphibians, and fish [2].
E. tarda human infections are rare and mainly present
as gastroenteritis; however, extraintestinal and systemic
infections have been reported that, when present, are a
potentially life-threatening condition carrying up to 50%
risk of mortality [3]. Such infections include bacteremia;
infections of skin, soft tissue, and biliary tract; liver and
tubo-ovarian abscesses; and peritonitis, particularly in
immunocompromised hosts [4, 5]. We report a case of
E. tarda infection that presented as multiple liver ab-
scesses leading to fulminant septic shock in a previously
healthy 37-year-old woman.
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Case presentation
A 37-year-old Southeast Asian woman presented to the
emergency department of our hospital with a 5-day his-
tory of abdominal pain, fever, and vomiting. Her past
medical history was unremarkable apart from a laparo-
scopic cholecystectomy 10months earlier. Upon presen-
tation, the patient had high-grade fever, tachycardia, and
hypotension suggestive of worsening sepsis, which even-
tually progressed rapidly to septic shock requiring high
doses of noradrenaline and vasopressin. She was intu-
bated, mechanically ventilated, and admitted to the in-
tensive care unit (ICU) accordingly. Upon ICU
admission, an abdominal computed tomographic (CT)
scan with contrast (Fig. 1) revealed hypodense lesions
occupying the right and left liver lobes with calcification
foci suspicious of abscesses as well as mild intra-
abdominal free fluid collection. Initial investigations re-
vealed a hemoglobin level of 10.4 g/dl and a white blood
cell count of 18.9 × 109/L with 89% neutrophils. Her
platelet count was normal. Her blood urea nitrogen was
raised at 12.1 mmol/L (normal range 2.5–6.4 mmol/L),
but her serum creatinine was within normal limits at
115 IU/L (normal range 71–115 IU/L). Her renal func-
tion was completely normalized following administration
of intravenous fluids a few hours after ICU admission.
The findings of blood film obtained for malarial para-
sites were negative. Notwithstanding this, liver function
tests were remarkable with a total bilirubin of
25.3 μmol/L (direct 13.6 μmol/L, indirect 11.7 μmol/L),
albumin 19.5 g/L, globulin 44.9 g/L, alkaline phosphatase
416 U/L, alanine aminotransferase 549 IU/L, aspartate
aminotransferase 765 IU/L, prothrombin time 16.5 with
international normalized ratio 1.41, activated partial
thromboplastin time 39.9 seconds, and glucose 5.5
mmol/L. The patient’s physical examination and chest x-
ray were unremarkable. CT-guided percutaneous
drainage of the liver abscesses with supplementary cul-
tures was performed while blood cultures were derived
accordingly. The analysis of the fluid drained from the
liver abscess showed a high white blood cell count
(11.8 × 103/μl) with polymorphic predominance (77%)
and high bilirubin and lactate dehydrogenase levels.
Moreover, a gram-stained smear of the pus aspirated
from the liver abscess showed few gram-negative bacilli
and necrotic debris. All blood cultures as well as stool
samples that were collected for 3 consecutive days grew
E. tarda [6]. Specifically, blood cultures were obtained
under sterile conditions and were processed using BacT/
ALERT 3D (bioMérieux, Marcy l’Etoile, France). Strains
of E. tarda were identified using the MicroScan Walk-
Away 96si system (Siemens, Erlangen, Germany). We
evaluated the drug susceptibility of the pathogen based
on clinical breakpoints set by the Clinical and Labora-
tory Standards Institute using E-test (bioMérieux) [7].
Notably, the results of all other infectious and systemic
disease workup were negative. Upon ICU admission,
piperacillin-tazobactam was initiated empirically (at a
dose of 4.5 g intravenously every 6 hours) because the
results of the aforementioned cultures were not available
at that time. Forty-eight hours later, due to lack of clin-
ical improvement and worsening shock despite fluid re-
suscitation, antibiotics were empirically once more
upgraded to meropenem (1 g every 8 hours by intraven-
ous infusion over 3 hours) and linezolid (600 mg intra-
venously every 12 hours). As mentioned in the
paragraphs above, all cultures grew E. tarda. The anti-
biogram (available when the patient had already received
the upgraded antibiotics for 48 hours) showed, interest-
ingly, that the pathogen was resistant to piperacillin-
tazobactam and carbapenems while being sensitive to
gentamicin and ciprofloxacin. Hence, the antibiotic regi-
men was updated to ciprofloxacin (400 mg intravenously
every 12 hours for 14 days) and gentamicin (400 mg
intravenously once daily for 14 days) on the basis of the
pertinent antibiogram. The clinical status of the patient
gradually improved, and she was successfully weaned off
vasopressors and the mechanical ventilator. She was dis-
charged from the ICU 14 days after admission. There-
after, she was transferred to the gastroenterology ward,
where follow-up endoscopic studies revealed mild non-
specific enteritis that eventually resolved completely, and
she was discharged from the hospital free of symptoms
and in good health.
Discussion
E. tarda, a member of the Enterobacteriaceae family, be-
longs to the genus Edwardsiella along with E. hoshinae
and E. ictaluri, and is a facultative anaerobic gram-
negative bacillus. It has a worldwide distribution espe-
cially in water environments, whereas its role as a fish
Fig. 1 Abdominal computed tomographic scan with contrast
revealing liver abscesses (black arrows) due to Edwardsiella
tarda infection
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pathogen has long been recognized [8]. Exposure to
water environments as well as aquatic animals (reptiles,
snakes, turtles, and amphibians), iron overload disorders,
and ingestion of contaminated raw fish were previously
reported as risk factors for infection [3]. Aeromonas spe-
cies, Vibrio vulnificus, and Mycobacterium marinum
share the same environment and therefore a similar ex-
posure risk to E. tarda; moreover, the clinical presenta-
tion of the former infections could be similar to E. tarda
infections. although M. marinum infections tend to be
generally idle and not associated with systemic manifes-
tations [9]. Humans appear to become uncommonly in-
fected with E. tarda. Mild gastroenteritis is the most
common manifestation associated with this pathogen, but
invasive enterocolitis and serious extraintestinal infections,
such as necrotizing fasciitis, sepsis, wound abscess,
gynecological infections, peritonitis, and osteomyelitis, have
been reported in individuals with underlying systemic dis-
eases such as malignancy, impaired immune status, diabetes
mellitus, and hepatobiliary diseases [8–10]. Although
gastrointestinal infections are generally self-limited [10], E.
tarda–related septicemia mortality ranges from 38% to
50%, and it should be considered a life-threatening condi-
tion [3, 11]. This suggests that a dysfunctional intestinal
barrier and/or immune system impairment related to
underlying conditions might play a key role in the bacterial
translocation across intestinal epithelium, which could in
turn facilitate systemic dissemination [11].
We report a case of a previously healthy woman who
developed liver abscesses and septic shock due to E. tarda
infection. Although our patient had a history of cholecyst-
ectomy 10months earlier, she did not have any history of
chronic illnesses and denied any exposure to aquatic envi-
ronments. All cultures that were derived prior to the em-
pirical administration of antibiotics grew E. tarda. We are
unaware whether previous cholecystectomy per se might
be considered as a risk factor for developing E. tarda in-
fection. A few case reports have outlined patients with a
history of cholecystectomy and E. tarda infection, but
those were also characterized by major underlying disor-
ders [4, 11]. Moreover, previously published articles re-
ported E. tarda infections that presented as liver abscesses
and/or bacteremia with variable modalities of manage-
ment and patient outcomes [3, 5, 11–15].
In vitro studies revealed that almost all E. tarda iso-
lates are susceptible to a wide range of antibacterial
agents (ampicillin, most β-lactam antibiotics, quinolones,
chloramphenicol, tetracycline, and aminoglycosides) that
are commonly used against gram-negative bacteria [16].
In our patient’s case, for the first time, to the best of our
knowledge, resistance to broad-spectrum antibiotics
such as carbapenems and piperacillin-tazobactam was
clearly documented, whereas the E. tarda strain was sus-
ceptible to ciprofloxacin and aminoglycosides.
Our patient improved gradually during her ICU
hospitalization. She finally survived despite the grave
clinical presentation of the infection. Surely, our patient
was immunocompetent and had no definitive risk factors
for E. tarda infection, as previously discussed. Moreover,
the patient was discharged from the hospital in good
health. She shared her appreciation and approval regard-
ing the received treatment and care. We speculate that
her survival may be at least partially attributed to both
the effective drainage of the liver abscess and the admin-
istration of culture-based specific antibiotic therapy
apart from the prompt initiation of supportive ICU care.
A currently growing body of literature has established E.
tarda as an unusual cause of serious infections associ-
ated with septic shock, even in immunocompetent hosts;
hence, intensivists should be aware of this potentially le-
thal pathogen.
Conclusion
E. tarda human infections could present as liver ab-
scesses and fulminant septic shock even in immunocom-
petent patients. E. tarda strains could be resistant to
broad-spectrum antibiotics; hence, culture-based antibi-
otics should be used accordingly. Clinicians should be
aware of this rare and potentially lethal infection.
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